Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.

@article{Caporali2004PrednisonePM,
  title={Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.},
  author={Roberto Caporali and Marco Amedeo Cimmino and Gianfranco Ferraccioli and Roberto Gerli and Catherine Klersy and Carlo Salvarani and Carlomaurizio Montecucco},
  journal={Annals of internal medicine},
  year={2004},
  volume={141 7},
  pages={493-500}
}
BACKGROUND Steroids are the standard treatment for polymyalgia rheumatica. The efficacy of the candidate drug methotrexate has not yet been demonstrated in controlled studies. OBJECTIVE To compare the efficacy and safety of prednisone plus methotrexate and prednisone alone in patients with polymyalgia rheumatica. DESIGN Multicenter randomized, double… CONTINUE READING